[New aspects in the pathogenesis of chronic venous insufficiency and the place of localized action of Venoruton].
Bekers
S
S
Zilstra
I
I
D000925:Anticoagulants / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000975:Antioxidants / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D014680:Veins / Q000187:drug effects; D014689:Venous Insufficiency / Q000188:drug therapy* / Q000473:pathology*
D000925:Anticoagulants; D000975:Antioxidants; D006896:Hydroxyethylrutoside; C005865:troxerutin